CatalystCorporate
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorsement shifts child obesity strategy away from GLP-1 drugs toward lifestyle changes.
What changed
WHO endorsement shifts child obesity strategy away from GLP-1 drugs toward lifestyle changes.
Why it matters
WHO endorsement shifts child obesity strategy away from GLP-1 drugs toward lifestyle changes. — impact context not separately stored; see What changed.
← Dashboard
Oct 07, 2026 10:28 AM ET